Search
for
Sort by
Research 241–270 of 1000+
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Dermatology of androgen-related disorders
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- New lifestyle drugs and somatoform disorders in dermatology
- Phytochemical Constitution, Anti-Inflammation, Anti-Androgen, and Hair Growth-Promoting Potential of Shallot (Allium ascalonicum L.) Extract
- Special Focus Issue: Transdermal, Topical and Folicular Drug Delivery Systems
- Quantitative Analysis Using the Phototrichogram Technique of an Italian Population Suffering from Androgenic Alopecia
- Hair aging and anti-aging
- Dermatological drugs, topical agents, and cosmetics
- Cutaneous Drug Reaction Case Reports
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- DRUG‐ASSOCIATED ALOPECIA
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- New drugs under investigation for the treatment of alopecias
- Lifestyle Drugs in Old Age – A Mini-Review
- Role of Non Androgenic Factors in Hair loss and Hair Regrowth
- New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Nanoporous Silica Entrapped Lipid-Drug Complexes for the Solubilization and Absorption Enhancement of Poorly Soluble Drugs
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Hormone Blocking Anticancer Drugs
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs